-The Indian Express Ganga Ram docs link ‘benign’ parasite with platelet drop, liver problems. A malaria parasite responsible for the milder form of the disease — Plasmodium vivax — has been linked with severe complications in Patients. A new study by Sir Ganga Ram Hospital doctors on 165 Patients, published in the journal Tropical Doctor, says the parasite may be deadlier than thought. Of 121 Patients diagnosed with vivax malaria, three died of...

-The Hindu Drugs Controller must be told of adverse events within 24 hours Under sharp criticism for inadequate monitoring of clinical trials in the country, the Union Government is contemplating major changes in the Drugs & Cosmetics Act, 1940, and its Rules. These would make it mandatory for the Investigator to report all serious adverse events, including deaths, to the Drugs Controller General of India (DGCI), as well as the sponsor and...

-Tehelka The sentencing of Wall Street wizard Rajat Gupta in the historic insider trading case has led to the fall of a one-time icon for many Indians “This is where destiny is taking me.” This is what former Goldman Sachs Group Inc director, Rajat Gupta, told old friend Pramod Bhasin, as he sat with a glass of scotch in hand, in a mid-town bar in New York. Little did Gupta know how prophetic...

-The Economic Times Nazia is 10 years old. But, according to a claim filed by Chhattisgarh-based Shaheed Hospital with the Rashtriya Swasthya Bima Yojna (RSBY), she has delivered a baby after a caesarean operation. Mukul (name changed) is only 7. But Agarwal Hospital, Raipur, has made a claim for removing cataract from his eyes. A large number of similar implausible claims, being made by private hospitals enrolled to treat poor Patients under...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...